FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897855420> ?p ?o ?g. }

• W2897855420 endingPage "1654" @default.
• W2897855420 startingPage "1646" @default.
• W2897855420 abstract "Background Heart failure (HF) is associated with high morbidity and mortality, and is a major contributor to health care costs. Since the area continues to be rapidly evolving, the aim of this study was to examine 15-year trends in demographics, precipitants, symptoms and outcomes of patients hospitalised with HF, and consider the individual and societal implications. Methods Data were prospectively collected by Heart Failure nurses from patients enrolled in the Management of Cardiac Function program (MACARF) in Northern Sydney, Australia. Analyses of trends were performed using Mantel-Hanzel tests and one-way analysis of variance. Multivariate Cox proportional hazard models were used to determine changes in readmission and mortality rates. Results From 2001 to 2015, 5,588 patients were hospitalised with HF and enrolled in the MACARF program. Over the 15-year period, the average age of enrolled patients increased by a decade (from 74 to 84 years), with an increase in hypertension (52% to 67%), chronic kidney disease (11% to 21%), atrial fibrillation/flutter (29% to 44%), and HF with preserved ejection fraction (24% to 35%) but a decrease in ischaemic heart disease (62% to 47%). Infection and atrial arrhythmias were the two most common precipitants of admission (27% and 18% of patients in 2013–15 respectively), while acute ischaemia became less common, and “unknown” precipitant increased to 35%. While increased exertional dyspnoea and peripheral oedema remained the most common presenting symptoms, weight gain, fatigue and chest pain were less frequently identified. Medication trends included an increase in spironolactone use and a decrease in angiotensin converting enzyme inhibitors. Average length of stay reduced while 1- and 3-year mortality rates improved to 11.3% and 26.6% respectively. In contrast, readmission rates have not improved, with current 30-day and 1-year rates of 9.9% and 42.6%. Conclusions Significant temporal changes have occurred in the characteristics and outcome of patients with HF, which pose a challenge and opportunity to improve management. Although length of stay and mortality have improved, unchanged readmission rates highlight the importance of addressing the implications of the changing nature of patients with HF. Heart failure (HF) is associated with high morbidity and mortality, and is a major contributor to health care costs. Since the area continues to be rapidly evolving, the aim of this study was to examine 15-year trends in demographics, precipitants, symptoms and outcomes of patients hospitalised with HF, and consider the individual and societal implications. Data were prospectively collected by Heart Failure nurses from patients enrolled in the Management of Cardiac Function program (MACARF) in Northern Sydney, Australia. Analyses of trends were performed using Mantel-Hanzel tests and one-way analysis of variance. Multivariate Cox proportional hazard models were used to determine changes in readmission and mortality rates. From 2001 to 2015, 5,588 patients were hospitalised with HF and enrolled in the MACARF program. Over the 15-year period, the average age of enrolled patients increased by a decade (from 74 to 84 years), with an increase in hypertension (52% to 67%), chronic kidney disease (11% to 21%), atrial fibrillation/flutter (29% to 44%), and HF with preserved ejection fraction (24% to 35%) but a decrease in ischaemic heart disease (62% to 47%). Infection and atrial arrhythmias were the two most common precipitants of admission (27% and 18% of patients in 2013–15 respectively), while acute ischaemia became less common, and “unknown” precipitant increased to 35%. While increased exertional dyspnoea and peripheral oedema remained the most common presenting symptoms, weight gain, fatigue and chest pain were less frequently identified. Medication trends included an increase in spironolactone use and a decrease in angiotensin converting enzyme inhibitors. Average length of stay reduced while 1- and 3-year mortality rates improved to 11.3% and 26.6% respectively. In contrast, readmission rates have not improved, with current 30-day and 1-year rates of 9.9% and 42.6%. Significant temporal changes have occurred in the characteristics and outcome of patients with HF, which pose a challenge and opportunity to improve management. Although length of stay and mortality have improved, unchanged readmission rates highlight the importance of addressing the implications of the changing nature of patients with HF." @default.
• W2897855420 created "2018-10-26" @default.
• W2897855420 creator A5060518530 @default.
• W2897855420 creator A5082288138 @default.
• W2897855420 creator A5089858920 @default.
• W2897855420 date "2019-11-01" @default.
• W2897855420 modified "2023-09-26" @default.
• W2897855420 title "15-Year Trends in Patients Hospitalised With Heart Failure and Enrolled in an Australian Heart Failure Management Program" @default.
• W2897855420 cites W1921489401 @default.
• W2897855420 cites W1964714332 @default.
• W2897855420 cites W1965781018 @default.
• W2897855420 cites W1966182783 @default.
• W2897855420 cites W1971568514 @default.
• W2897855420 cites W1973380773 @default.
• W2897855420 cites W1975692469 @default.
• W2897855420 cites W2071522338 @default.
• W2897855420 cites W2087093792 @default.
• W2897855420 cites W2093664139 @default.
• W2897855420 cites W2104209472 @default.
• W2897855420 cites W2105204298 @default.
• W2897855420 cites W2121200570 @default.
• W2897855420 cites W2129094446 @default.
• W2897855420 cites W2131260805 @default.
• W2897855420 cites W2137784332 @default.
• W2897855420 cites W2146180264 @default.
• W2897855420 cites W2152072062 @default.
• W2897855420 cites W2153692392 @default.
• W2897855420 cites W2153903059 @default.
• W2897855420 cites W2155034492 @default.
• W2897855420 cites W2159219753 @default.
• W2897855420 cites W2165363952 @default.
• W2897855420 cites W2167760816 @default.
• W2897855420 cites W2167831956 @default.
• W2897855420 cites W2266559694 @default.
• W2897855420 cites W2297270956 @default.
• W2897855420 cites W2313958625 @default.
• W2897855420 cites W2323862874 @default.
• W2897855420 cites W2324073140 @default.
• W2897855420 cites W2373270107 @default.
• W2897855420 cites W2416483093 @default.
• W2897855420 cites W2514045532 @default.
• W2897855420 cites W2570927149 @default.
• W2897855420 cites W2607201764 @default.
• W2897855420 cites W2613695111 @default.
• W2897855420 cites W2775066728 @default.
• W2897855420 cites W2786781710 @default.
• W2897855420 cites W2789914818 @default.
• W2897855420 cites W2791404777 @default.
• W2897855420 cites W2793372684 @default.
• W2897855420 cites W2803051909 @default.
• W2897855420 cites W3023363600 @default.
• W2897855420 doi "https://doi.org/10.1016/j.hlc.2018.10.010" @default.
• W2897855420 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31631860" @default.
• W2897855420 hasPublicationYear "2019" @default.
• W2897855420 type Work @default.
• W2897855420 sameAs 2897855420 @default.
• W2897855420 citedByCount "9" @default.
• W2897855420 countsByYear W28978554202020 @default.
• W2897855420 countsByYear W28978554202021 @default.
• W2897855420 countsByYear W28978554202022 @default.
• W2897855420 crossrefType "journal-article" @default.
• W2897855420 hasAuthorship W2897855420A5060518530 @default.
• W2897855420 hasAuthorship W2897855420A5082288138 @default.
• W2897855420 hasAuthorship W2897855420A5089858920 @default.
• W2897855420 hasConcept C126322002 @default.
• W2897855420 hasConcept C164705383 @default.
• W2897855420 hasConcept C194828623 @default.
• W2897855420 hasConcept C207103383 @default.
• W2897855420 hasConcept C2776379505 @default.
• W2897855420 hasConcept C2778198053 @default.
• W2897855420 hasConcept C2779161974 @default.
• W2897855420 hasConcept C44249647 @default.
• W2897855420 hasConcept C50382708 @default.
• W2897855420 hasConcept C71924100 @default.
• W2897855420 hasConcept C78085059 @default.
• W2897855420 hasConceptScore W2897855420C126322002 @default.
• W2897855420 hasConceptScore W2897855420C164705383 @default.
• W2897855420 hasConceptScore W2897855420C194828623 @default.
• W2897855420 hasConceptScore W2897855420C207103383 @default.
• W2897855420 hasConceptScore W2897855420C2776379505 @default.
• W2897855420 hasConceptScore W2897855420C2778198053 @default.
• W2897855420 hasConceptScore W2897855420C2779161974 @default.
• W2897855420 hasConceptScore W2897855420C44249647 @default.
• W2897855420 hasConceptScore W2897855420C50382708 @default.
• W2897855420 hasConceptScore W2897855420C71924100 @default.
• W2897855420 hasConceptScore W2897855420C78085059 @default.
• W2897855420 hasIssue "11" @default.
• W2897855420 hasLocation W28978554201 @default.
• W2897855420 hasLocation W28978554202 @default.
• W2897855420 hasOpenAccess W2897855420 @default.
• W2897855420 hasPrimaryLocation W28978554201 @default.
• W2897855420 hasRelatedWork W2051712573 @default.
• W2897855420 hasRelatedWork W2091139515 @default.
• W2897855420 hasRelatedWork W2187526770 @default.
• W2897855420 hasRelatedWork W2355594703 @default.
• W2897855420 hasRelatedWork W2978597367 @default.
• W2897855420 hasRelatedWork W3029306217 @default.
• W2897855420 hasRelatedWork W3033076790 @default.

• next